Advertisement

Topics

St. Jude, Abbott to divest products to Terumo for $1.12bn

00:38 EDT 19 Oct 2016 | Medical Business Review

St. Jude Medical and Abbott have agreed in principle to divest some of their cardiovascular products to Japanese firm Terumo for about $1.12bn.

Original Article: St. Jude, Abbott to divest products to Terumo for $1.12bn

NEXT ARTICLE

More From BioPortfolio on "St. Jude, Abbott to divest products to Terumo for $1.12bn"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...